Manchester Royal Infirmary Virtual Biologics Clinic
gastroenterology and dermatology, including at an event for the National IBD audit. Implementing up-to-date high-quality research...
Search results
15 results for ibd
-
-
Colonoscopic surveillance in adults with Ulcerative colitis, Crohn's disease or adenomas - Is this happening?
and over with ulcerative colitis or Crohn's disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to...
-
eXroid for internal haemorrhoids (MIB201)
NICE has developed a medtech innovation briefing (MIB) on eXroid for internal haemorrhoids
-
PredictSure-IBD for inflammatory bowel disease prognosis (MIB178)
Advice on PredictSure-IBD for inflammatory bowel disease prognosis to aid local decision making
-
The New Faecal Calprotectin Care Pathway
guidance DG11, for the detection of inflammation in the bowel (i.e. IBS vs IBD). Uptake of this guidance has previously been poor and...
-
Biosimilar medicines (KTT15)
The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .
-
Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)
NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory
-
RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)
NICE has developed a medtech innovation briefing (MIB) on RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease
-
Implementing faecal calprotectin testing in primary care
option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD) or irritable bowel...
-
Irritable bowel syndrome in adults (QS114)
This quality standard covers diagnosing and managing irritable bowel syndrome in adults. It describes high-quality care in priority areas for improvement.
-
Evaluation of guidelines for the use of faecal calprotectin testing in primary care
cancer is not suspected and it is used to support a diagnosis of inflammatory bowel disease (IBD) or irritable bowel...
-
Ulcerative colitis: budesonide multimatrix (Cortiment) (ESNM58)
Summary of the evidence on budesonide multimatrix (Cortiment) for treating ulcerative colitis (UC) to inform local NHS planning and decision-making
-
Therapeutic Review- A NICE way to optimise prescribing
use of: - Biologics in Rheumatoid Arthritis(RA), Psoriasis & Inflammatory Bowel Disease (IBD) using NICE algorithms &...
-
Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)
Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection
-
Inflammatory bowel disease (QS81)
This quality standard covers diagnosing and managing inflammatory bowel disease (Crohn’s disease and ulcerative colitis) in adults, young people and children. It describes high-quality care in priority areas for improvement.